Navigation Links
Botox Competitor Cleared to Re-Enter the Market
Date:1/20/2013

Los Angeles, CA (PRWEB) January 20, 2013

“I don’t see how this can be anything but a good thing for consumers,” opines Dr. Ourian, Medical Director of Epione Beverly Hills. “First there was Botox, then Dysport and now Xeomin, each with certain distinct attributes. This can only enable me to do a better job of serving the needs of my patients.”

The injunction, issued by a U.S. District Judge on March 9, 2012, prevented Merz USA from doing a full commercial launch of Xeomin, the wrinkle-busting drug it developed to compete against market leader Allergan’s Botox. The judge concluded that several salespeople hired away from Allergan by Merz took confidential client information and market research when they left. (go to: goo.gl/IvkbK)

“Regardless of which treatment option you choose, consumers need to be smart and safe about the doctor they choose,” says Dr. Ourian. “That why I recently created a six-point Botox checklist.”

  •     It’s important to know who is going to do the actual treatment. Will it be a physician or an RN. Do your research and ask friends and family for referrals.
  •     In California only a physician can conduct the examination and consultation required before a prescription for Botox, Dysport or Xeomin is issued.
  •     These are medical treatments and should only be done in a medical office setting.
  •     Make certain you understand the post-treatment instructions.
  •     Confirm that whatever product you choose to be injected with (Botox, Dysport or Xeomin) is the authentic product manufactured by Allergan, Medicis or Merz respectively. The U.S. Food & Drug Administration recently warned 350 medical practices about their importation of unapproved Botox from a Canadian pharmacy. (go to: goo.gl/WC3fX)
  •     Don’t be afraid to ask questions.

For more information about Botox Competitor Cleared to Re-Enter the Market click here.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10340972.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Botox Offers Little Relief for Migraine, Study Finds
2. Botox May Ease Tremors in Multiple Sclerosis Patients
3. Botox beats steroids for painful foot condition, plantar fasciitis
4. FDA Gives Nod to Botox to Treat Overactive Bladder
5. The Stone Bake Oven Company: UK Wood Fired Ovens Are Coming Up Trumps Over International Competitors
6. Passengers on Bat Plane Cleared of Rabies Risk
7. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
8. Majority of states fail to address youth exposure to alcohol marketing
9. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
10. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
11. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: